Nerveblocks for Persistent Pain After Breast Cancer Surgery
NCT ID: NCT02336529
Last Updated: 2015-10-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
48 participants
INTERVENTIONAL
2016-07-31
2017-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevention of Post-Mastectomy Breast Pain Using Ambulatory Continuous Paravertebral Blocks
NCT01231204
Effect of Pectoral Nerve Block on Post-op Pain in Patients Undergoing Mastectomy and Immediate Reconstruction
NCT02913573
Neuropathic Pain in Survivors of Breast Cancer
NCT00535067
Reducing Pain and Disability After Breast Cancer Surgery
NCT01089933
Paravertebral Blocks for Breast Cancer Surgery
NCT01904266
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DIAGNOSTIC
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ICBN, active
Ultrasound guided injection of bupivacain, 10mL, 0.5% in proximity of the ICBN
Bupivacaine
ICBN, placebo
Ultrasound guided injection of NaCl, 10mL in proximity of the ICBN
NaCl
Tenderpoint, active
Ultrasound guided injection of bupivacain, 20mL, 0.25% in the tenderpoint
Bupivacaine
Tenderpoint, placebo
Ultrasound guided injection of NaCl, 20mL in the tenderpoint
NaCl
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bupivacaine
NaCl
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women aged 18 or over
* Suffering from persistent pain in the breast, side of chest, axilla or arm (NRS 4 or over)
Exclusion Criteria
* bilateral cancer
* pregnant or lactating
* other disease in the nervous system
* in treatment for psychiatric disease
* unable to understand Danish
* unable to give informed concent
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kenneth Geving Andersen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kenneth Geving Andersen
Research fellow
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nelun Wijayasinghe, MD
Role: PRINCIPAL_INVESTIGATOR
Rigshospitalet, University of Copenhagen
Kenneth G Andersen, MD, PhD
Role: STUDY_CHAIR
Rigshospitalet, University of Copenhagen
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Wijayasinghe N, Andersen KG, Kehlet H. Neural blockade for persistent pain after breast cancer surgery. Reg Anesth Pain Med. 2014 Jul-Aug;39(4):272-8. doi: 10.1097/AAP.0000000000000101.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-3-2013-172
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.